Doctors Information

In order to raise greater awareness about the diagnosis of the COVID-19 infection by PCR and to determine a patient’s state of recovery for the gradual lifting of the lockdown, the BioneXt LAB laboratory is able to offer SARS-CoV-2 serology by looking for total antibodies (IgA, IgM, IgG) produced in response to an infection by this virus.

You are kindly requested to read the corresponding newsletter.

For all inquiries as well as for orders of sampling kits, you can send an email to : coronavirus@bionext.lu

Fully integrated into your practice software, myLAB allows :

• securely access your patients' latest results with automatic highlighting of anomalous results and new, unread results
• filter analyses by various criteria,
• generate comparative charts of selected previous results
• generate combined tables with markers
• generate PDF files to print test results
• generate an electronic prescription incorporating the rules of the current nomenclature
• make an appointment for a blood test for your patient

Discover all the features of myLAB on www.bionext.lu/santemobile and download the application on

If we carry out almost all the analyzes entrusted to us, some rare analyzes are sent to specialized partner laboratories. We also perform many exams for other laboratories, including hospitals.

Trisomy is a genetic anomaly that is characterized by the presence of an extra chromosome in the cells of a fetus. The trisomy most frequently encountered in humans is trisomy 21, followed by trisomy’s 18 and 13.

BioneXt LAB can now perform routine screening for circulating tumour DNA (ctDNA) released into the bloodstream when tumour cells die.

This technique, dubbed ‘liquid biopsy’, harnesses next-generation sequencing technology to screen plasma for mutated tumour DNA from carcinomas of the liver, stomach, pancreas, oesophagus, prostate gland, endometrium, head and neck region, kidneys, thyroid, and bladder—sometimes detecting tumours even before they are visible through medical imaging.

For more details, contact us by phone at 285 777 885 or e-mail at onconeXt@bionext.lu.

Our catalogue allows you to access essential information on the range of medical biology analyses offered by the laboratory.